CURIS, INC. Operating Lease, Payments
CURIS, INC. (CRIS) reported Operating Lease, Payments of $300.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Other Cash Flow Items
us-gaap:OperatingLeasePayments · last filed 2026-08-14
- CURIS, INC. operating lease, payments for the quarter ending 2026-06-30 was $300.00K, a 25.00% decline year-over-year.
- CURIS, INC. operating lease, payments for the quarter ending 2026-03-31 was $300.00K, a 25.00% decline year-over-year.
- CURIS, INC. operating lease, payments for the quarter ending 2025-12-31 was $400.00K, a 0.00% change year-over-year.
- CURIS, INC. operating lease, payments for the quarter ending 2025-09-30 was $400.00K, a 0.00% change year-over-year.
- CURIS, INC. operating lease, payments for fiscal 2025 was $1.60M, a 6.67% increase from fiscal 2024.
- CURIS, INC. operating lease, payments for fiscal 2024 was $1.50M, a 0.00% change from fiscal 2023.
- CURIS, INC. operating lease, payments for fiscal 2023 was $1.50M.
- CURIS, INC. operating lease, payments for fiscal 2019 was $1.00M.
| Period end | Operating Lease, Payments 3 month | Operating Lease, Payments 6 month | Operating Lease, Payments 9 month | Operating Lease, Payments 12 month |
|---|---|---|---|---|
| 2026-06-30 | $300.00K 10-Q · filed 2026-08-14 | $600.00K 10-Q · filed 2026-08-14 | $1.00M derived: sum of 3 quarters · filed 2026-08-14 | $1.40M derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | $300.00K 10-Q · filed 2026-05-13 | $700.00K derived: sum of 2 quarters · filed 2026-05-13 | $1.10M derived: sum of 3 quarters · filed 2026-05-13 | $1.50M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | $400.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24 | $800.00K derived: sum of 2 quarters · filed 2026-03-24 | $1.20M derived: sum of 3 quarters · filed 2026-08-14 | $1.60M 10-K · filed 2026-03-24 |
| 2025-09-30 | $400.00K 10-Q · filed 2025-11-06 | $800.00K derived: sum of 2 quarters · filed 2026-08-14 | $1.20M 10-Q · filed 2025-11-06 | $1.60M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | $400.00K 10-Q · filed 2026-08-14 | $800.00K 10-Q · filed 2026-08-14 | $1.20M derived: sum of 3 quarters · filed 2026-08-14 | $1.60M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | $400.00K 10-Q · filed 2026-05-13 | $800.00K derived: sum of 2 quarters · filed 2026-05-13 | $1.20M derived: sum of 3 quarters · filed 2026-05-13 | $1.60M derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | $400.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $800.00K derived: sum of 2 quarters · filed 2025-11-06 | $1.20M derived: sum of 3 quarters · filed 2025-11-06 | $1.50M 10-K · filed 2025-03-31 |
| 2024-09-30 | $400.00K 10-Q · filed 2025-11-06 | $800.00K derived: sum of 2 quarters · filed 2025-11-06 | $1.10M 10-Q · filed 2025-11-06 | $1.60M derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | $400.00K 10-Q · filed 2025-08-05 | $800.00K 10-Q · filed 2025-08-05 | $1.20M derived: sum of 3 quarters · filed 2025-08-05 | $1.60M derived: sum of 4 quarters · filed 2025-08-05 |
| 2024-03-31 | $400.00K 10-Q · filed 2025-05-06 | $800.00K derived: sum of 2 quarters · filed 2025-05-06 | $1.20M derived: sum of 3 quarters · filed 2025-05-06 | $1.60M derived: sum of 4 quarters · filed 2025-05-06 |
| 2023-12-31 | $400.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-08 | $800.00K derived: sum of 2 quarters · filed 2024-11-14 | $1.20M derived: sum of 3 quarters · filed 2024-11-14 | $1.50M 10-K · filed 2024-02-08 |
| 2023-09-30 | $400.00K 10-Q · filed 2024-11-14 | $800.00K derived: sum of 2 quarters · filed 2024-11-14 | $1.10M 10-Q · filed 2024-11-14 | $2.50M derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | $400.00K 10-Q · filed 2024-08-01 | $700.00K 10-Q · filed 2024-08-01 | $2.10M derived: sum of 3 quarters · filed 2024-08-01 | $2.50M derived: sum of 4 quarters · filed 2024-08-01 |
| 2023-03-31 | $400.00K 10-Q · filed 2024-05-07 | $1.70M derived: sum of 2 quarters · filed 2024-05-07 | $2.10M derived: sum of 3 quarters · filed 2024-05-07 | $2.40M derived: sum of 4 quarters · filed 2024-05-07 |
| 2022-12-31 | $1.30M 10-K · filed 2023-03-13 | $1.70M derived: sum of 2 quarters · filed 2023-11-02 | $2.00M derived: sum of 3 quarters · filed 2023-11-02 | $2.30M derived: sum of 4 quarters · filed 2023-11-02 |
| 2022-09-30 | $400.00K 10-Q · filed 2023-11-02 | $700.00K derived: sum of 2 quarters · filed 2023-11-02 | $1.00M 10-Q · filed 2023-11-02 | |
| 2022-06-30 | $300.00K 10-Q · filed 2023-08-03 | $600.00K 10-Q · filed 2023-08-03 | ||
| 2022-03-31 | $300.00K 10-Q · filed 2023-05-04 | |||
| 2021-09-30 | $300.00K 10-Q · filed 2022-11-09 | $600.00K derived: sum of 2 quarters · filed 2022-11-09 | $2.00M 10-Q · filed 2022-11-09 | |
| 2021-06-30 | $300.00K 10-Q · filed 2022-08-04 | $1.70M 10-Q · filed 2022-08-04 | ||
| 2021-03-31 | $1.40M 10-Q · filed 2022-05-05 | |||
| 2020-09-30 | $0.00 10-Q · filed 2021-11-09 | $0.00 derived: sum of 2 quarters · filed 2021-11-09 | $200.00K 10-Q · filed 2021-11-09 | |
| 2020-06-30 | $0.00 10-Q · filed 2021-08-03 | $200.00K 10-Q · filed 2021-08-03 | ||
| 2019-12-31 | $200.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-19 | $500.00K derived: sum of 2 quarters · filed 2020-11-10 | $800.00K derived: sum of 3 quarters · filed 2020-11-10 | $1.00M 10-K · filed 2020-03-19 |
| 2019-09-30 | $300.00K 10-Q · filed 2020-11-10 | $600.00K derived: sum of 2 quarters · filed 2020-11-10 | $800.00K 10-Q · filed 2020-11-10 | |
| 2019-06-30 | $300.00K 10-Q · filed 2020-08-04 | $500.00K 10-Q · filed 2020-08-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |